Biofrontera Inc. Proceeds from Warrant Exercises
Biofrontera Inc. (BFRI) reported Proceeds from Warrant Exercises of $4.63 million for the 12-month period ending 2022-12-31, per its 8-K filed 2023-10-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2024-03-15
| Period end | Proceeds from Warrant Exercises 0 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|
| 2022-12-31 | $4.63M 8-K · filed 2023-10-03 | |
| 2022-07-26 | $4.60M 10-K · filed 2024-03-15 | |
| 2021-12-31 | $13.25M 8-K · filed 2023-10-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |